Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Schultz

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Advanced Healthcare Materials|July 2, 2013
Titanium microbead-based porous implants: bead size controls cell response and host integrationNihal Engin Vrana, Agnès Dupret-Bories, Philippe Schultz, et al.
Chinese Clinical Oncology|September 6, 2018
Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areasThomas Ohnleiter, Delphine Antoni, François Lefebvre, et al.
Biomaterials|December 9, 2004
Polyelectrolyte multilayers functionalized by a synthetic analogue of an anti-inflammatory peptide, alpha-MSH, for coating a tracheal prosthesisPhilippe Schultz, Dominique Vautier, Ludovic Richert, et al.
Clinical and Translational Allergy|December 27, 2022
Laryngeal dysfunction is prominent in asthmatic women treated by inhaled corticosteroidsNicolas Migueres, Christina Delmas, Julie Petit Thomas, et al.
Acta Haematologica|August 7, 2010
Lessons from a case of oromandibular mucormycosis treated with surgery and a combination of amphotericin B lipid formulation plus caspofunginMario Ojeda-Uribe, Raoul Herbrecht, Marie Hélène Kiefer, et al.
Cells|September 23, 2022
The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune ResponseJustine De Azevedo, Jana Mourtada, Cyril Bour, et al.
Ear, Nose, & Throat Journal|February 27, 2020
Risk Factors for Pharyngocutaneous Fistula After Total PharyngolaryngectomyEmilien Lemaire, Philippe Schultz, Sébastien Vergez, et al.
Journal of Vestibular Research : Equilibrium & Orientation|July 5, 2021
Present and future of the labyrinth imaging: Focus on the use of T2-weighted and contrast-enhanced delayed FLAIR (1 h) sequencesFrancis Veillon, Sophie Riehm, Michael Eliezer, et al.
BMC Cancer|December 9, 2023
Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE studyCarinato Hélène, Ombline Conrad, Carole Pflumio, et al.
Oral Oncology|March 30, 2017
Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar studyJean Lacau St Guily, Alexandra Rousseau, Bertrand Baujat, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Advanced Healthcare Materials|July 2, 2013
Titanium microbead-based porous implants: bead size controls cell response and host integrationNihal Engin Vrana, Agnès Dupret-Bories, Philippe Schultz, et al.
Chinese Clinical Oncology|September 6, 2018
Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areasThomas Ohnleiter, Delphine Antoni, François Lefebvre, et al.
Biomaterials|December 9, 2004
Polyelectrolyte multilayers functionalized by a synthetic analogue of an anti-inflammatory peptide, alpha-MSH, for coating a tracheal prosthesisPhilippe Schultz, Dominique Vautier, Ludovic Richert, et al.
Clinical and Translational Allergy|December 27, 2022
Laryngeal dysfunction is prominent in asthmatic women treated by inhaled corticosteroidsNicolas Migueres, Christina Delmas, Julie Petit Thomas, et al.
Acta Haematologica|August 7, 2010
Lessons from a case of oromandibular mucormycosis treated with surgery and a combination of amphotericin B lipid formulation plus caspofunginMario Ojeda-Uribe, Raoul Herbrecht, Marie Hélène Kiefer, et al.
Cells|September 23, 2022
The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune ResponseJustine De Azevedo, Jana Mourtada, Cyril Bour, et al.
Ear, Nose, & Throat Journal|February 27, 2020
Risk Factors for Pharyngocutaneous Fistula After Total PharyngolaryngectomyEmilien Lemaire, Philippe Schultz, Sébastien Vergez, et al.
Journal of Vestibular Research : Equilibrium & Orientation|July 5, 2021
Present and future of the labyrinth imaging: Focus on the use of T2-weighted and contrast-enhanced delayed FLAIR (1 h) sequencesFrancis Veillon, Sophie Riehm, Michael Eliezer, et al.
BMC Cancer|December 9, 2023
Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE studyCarinato Hélène, Ombline Conrad, Carole Pflumio, et al.
Oral Oncology|March 30, 2017
Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar studyJean Lacau St Guily, Alexandra Rousseau, Bertrand Baujat, et al.
Pageof 5